(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | -29.23%3.7M | 8.95%10.26M | 62.65%5.23M | -13.57%9.41M | 12.79%3.22M | 234.18%10.89M | --2.85M | -59.63%3.26M | --8.07M |
Operating income | -29.23%3.7M | 8.95%10.26M | 62.65%5.23M | -13.57%9.41M | 12.79%3.22M | 234.18%10.89M | 2.85M | -59.63%3.26M | 8.07M |
Cost of sales | 37.91%-750K | -44.33%-3.03M | -59.79%-1.21M | 2.37%-2.1M | -16.31%-756K | -185.39%-2.15M | ---650K | 64.04%-753K | ---2.09M |
Operating expenses | 37.91%-750K | -44.33%-3.03M | -59.79%-1.21M | 2.37%-2.1M | -16.31%-756K | -185.39%-2.15M | -650K | 64.04%-753K | -2.09M |
Gross profit | -26.63%2.95M | -1.20%7.23M | 63.53%4.03M | -16.32%7.32M | 11.76%2.46M | 248.84%8.74M | 2.2M | -58.08%2.51M | 5.98M |
Selling expenses | 41.01%-3.76M | -2.65%-11.49M | -20.09%-6.37M | 11.94%-11.19M | 6.00%-5.3M | -100.03%-12.71M | ---5.64M | 26.22%-6.35M | ---8.61M |
Administrative expenses | 21.81%-3.6M | 3.25%-8.93M | -8.17%-4.61M | 50.24%-9.23M | 64.27%-4.26M | -140.17%-18.55M | ---11.93M | 12.80%-7.72M | ---8.86M |
Research and development expenses | 36.56%-6.49M | -5.15%-20.15M | -11.97%-10.23M | -14.37%-19.17M | -17.83%-9.14M | -79.18%-16.76M | ---7.76M | 17.78%-9.35M | ---11.38M |
Revaluation surplus | ---- | ---- | ---- | ---- | ---- | -620.04%-198.87M | ---22.04M | -192.34%-27.62M | ---9.45M |
-Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | -620.04%-198.87M | ---22.04M | -192.34%-27.62M | ---9.45M |
Impairment and provision | -320.90%-444K | 127.63%121K | 244.60%201K | 25.00%-438K | -297.14%-139K | -172.90%-584K | ---35K | -970.00%-214K | ---20K |
-Other impairment is provision | -320.90%-444K | 127.63%121K | 244.60%201K | 25.00%-438K | -297.14%-139K | -172.90%-584K | ---35K | -970.00%-214K | ---20K |
Special items of operating profit | 50.46%3.45M | 9.26%5.22M | 521.41%2.29M | 75.35%4.77M | -83.11%369K | 340.45%2.72M | --2.19M | 107.38%618K | --298K |
Operating profit | 46.28%-7.89M | -0.25%-28.01M | 8.25%-14.69M | 88.16%-27.94M | 62.78%-16.01M | -390.28%-236.01M | -43.01M | -50.28%-48.14M | -32.03M |
Financing cost | -18.60%-51K | 15.31%-83K | 17.31%-43K | 42.35%-98K | 52.73%-52K | 73.72%-170K | ---110K | -25.15%-647K | ---517K |
Earning before tax | 46.09%-7.94M | -0.20%-28.09M | 8.28%-14.73M | 88.13%-28.03M | 62.75%-16.06M | -384.12%-236.18M | -43.12M | -49.88%-48.78M | -32.55M |
Tax | 0.00%-2K | 0.00%-3K | -100.00%-2K | 0.00%-3K | 0.00%-1K | -50.00%-3K | ---1K | 0.00%-2K | ---2K |
After-tax profit from continuing operations | 46.08%-7.94M | -0.20%-28.09M | 8.28%-14.73M | 88.13%-28.04M | 62.75%-16.06M | -384.11%-236.18M | -43.12M | -49.88%-48.79M | -32.55M |
Earning after tax | 46.08%-7.94M | -0.20%-28.09M | 8.28%-14.73M | 88.13%-28.04M | 62.75%-16.06M | -384.11%-236.18M | -43.12M | -49.88%-48.79M | -32.55M |
Minority profit | ---- | ---1K | ---- | ---- | ---- | 28.23%-394K | ---394K | 11.74%-549K | ---622K |
Profit attributable to shareholders | 46.08%-7.94M | -0.20%-28.09M | 8.28%-14.73M | 88.11%-28.04M | 62.41%-16.06M | -388.80%-235.78M | -42.72M | -51.08%-48.24M | -31.93M |
Basic earnings per share | 33.33%-0.02 | 0.00%-0.06 | 0.00%-0.03 | 92.41%-0.06 | 84.21%-0.03 | -259.09%-0.79 | -0.19 | -57.14%-0.22 | -0.14 |
Diluted earnings per share | 33.33%-0.02 | 0.00%-0.06 | 0.00%-0.03 | 92.41%-0.06 | 84.21%-0.03 | -259.09%-0.79 | -0.19 | -57.14%-0.22 | -0.14 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data